Literature DB >> 20446031

A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer.

Ying Liu1, Maria Pérez, Mario Schootman, Rebecca L Aft, William E Gillanders, Matthew J Ellis, Donna B Jeffe.   

Abstract

Breast cancer patients' perceived risk of recurrence has been associated with psychological distress. Little is known about the change of patients' perceived risk of recurrence over time and factors associated with their recurrence-risk perceptions. We prospectively recruited 549 newly diagnosed early-stage breast cancer patients; patients completed interviews at 6 weeks, 6 months, 1 year, and 2 years after definitive surgical treatment. A random-effects regression model with repeated ordinal measurements was used to estimate the relationship between perceived risk of recurrence and demographic, medical, and psychosocial factors. We analyzed data from 535 patients [34% ductal carcinoma in situ (DCIS); 20% non-white] who reported their perceived risk at one or more interviews. At the first interview, 16% reported having no lifetime risk of recurrence, and another 16% reported ≥ 50% risk of recurrence, including 15% of DCIS patients. Patients who were white (OR = 5.88, 95% CI 3.39-10.19) and had greater state anxiety (OR = 1.04, 95% CI 1.02-1.07) were more likely, while patients who received radiotherapy (OR = 0.72, 95% CI 0.54-0.96) and had more social support (OR = 0.59, 95% CI 0.46-0.75) were less likely to report higher risk of recurrence. Cancer stage was not significantly associated with perceived risk of recurrence. Perceived risk of recurrence did not change significantly over time. Educating early-stage breast cancer patients about their actual risk could result in more realistic recurrence-risk perceptions, and increasing social support could help alleviate anxiety associated with exaggerated risk perceptions.

Entities:  

Mesh:

Year:  2010        PMID: 20446031      PMCID: PMC3227389          DOI: 10.1007/s10549-010-0912-1

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  50 in total

Review 1.  Analysis of longitudinal substance use outcomes using ordinal random-effects regression models.

Authors:  D Hedeker; R J Mermelstein
Journal:  Addiction       Date:  2000-11       Impact factor: 6.526

2.  Responsiveness to threats and incentives, expectancy of recurrence, and distress and disengagement: moderator effects in women with early stage breast cancer.

Authors:  C S Carver; B Meyer; M H Antoni
Journal:  J Consult Clin Psychol       Date:  2000-12

3.  Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

Authors:  N Bijker; J L Peterse; L Duchateau; J P Julien; I S Fentiman; C Duval; S Di Palma; J Simony-Lafontaine; I de Mascarel; M J van de Vijver
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

4.  Involvement in decision-making and breast cancer survivor quality of life.

Authors:  M R Andersen; N Urban
Journal:  Ann Behav Med       Date:  1999

5.  Local recurrence following breast conservation therapy in African-American women with invasive breast cancer.

Authors:  C S Connor; A K Touijer; L Krishnan; M S Mayo
Journal:  Am J Surg       Date:  2000-01       Impact factor: 2.565

6.  Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ.

Authors:  L G Bluman; N A Borstelmann; B K Rimer; J D Iglehart; E P Winer
Journal:  J Womens Health Gend Based Med       Date:  2001 Jul-Aug

7.  Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.

Authors:  H Bartelink; J C Horiot; P Poortmans; H Struikmans; W Van den Bogaert; I Barillot; A Fourquet; J Borger; J Jager; W Hoogenraad; L Collette; M Pierart
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

8.  Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.

Authors:  A C Voogd; M Nielsen; J L Peterse; M Blichert-Toft; H Bartelink; M Overgaard; G van Tienhoven; K W Andersen; R J Sylvester; J A van Dongen
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

9.  Social support as a buffer to the psychological impact of stressful life events in women with breast cancer.

Authors:  A B Kornblith; J E Herndon; E Zuckerman; C M Viscoli; R I Horwitz; M R Cooper; L Harris; K H Tkaczuk; M C Perry; D Budman; L C Norton; J Holland
Journal:  Cancer       Date:  2001-01-15       Impact factor: 6.860

10.  Perceived cancer risk: why is it lower among nonwhites than whites?

Authors:  Heather Orom; Marc T Kiviniemi; Willie Underwood; Levi Ross; Vickie L Shavers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02-16       Impact factor: 4.254

View more
  21 in total

1.  Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop.

Authors:  Ann H Partridge; Joann G Elmore; Debbie Saslow; Worta McCaskill-Stevens; Stuart J Schnitt
Journal:  CA Cancer J Clin       Date:  2012-04-04       Impact factor: 508.702

2.  Pre-Existing Diabetes in Early Stage Breast Cancer Patients is Associated with Lack of Improvement in Quality of Life 2 Years After Diagnosis.

Authors:  Soghra Jarvandi; Maria Pérez; Mario Schootman; Donna B Jeffe
Journal:  Int J Behav Med       Date:  2016-12

3.  Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.

Authors:  Shoshana M Rosenberg; Karen Sepucha; Kathryn J Ruddy; Rulla M Tamimi; Shari Gelber; Meghan E Meyer; Lidia Schapira; Steven E Come; Virginia F Borges; Mehra Golshan; Eric P Winer; Ann H Partridge
Journal:  Ann Surg Oncol       Date:  2015-05-01       Impact factor: 5.344

4.  Health behavior change following a diagnosis of ductal carcinoma in situ: An opportunity to improve health outcomes.

Authors:  Amy M Berkman; Amy Trentham-Dietz; Kim Dittus; Vicki Hart; Christine M Vatovec; John G King; Ted A James; Susan G Lakoski; Brian L Sprague
Journal:  Prev Med       Date:  2015-04-06       Impact factor: 4.018

5.  Early-stage breast cancer and employment participation after 2 years of follow-up: A comparison with age-matched controls.

Authors:  Christine C Ekenga; Maria Pérez; Julie A Margenthaler; Donna B Jeffe
Journal:  Cancer       Date:  2018-02-13       Impact factor: 6.860

6.  Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer.

Authors:  Ying Liu; Maria Pérez; Mario Schootman; Rebecca L Aft; William E Gillanders; Donna B Jeffe
Journal:  Breast Cancer Res Treat       Date:  2011-05-08       Impact factor: 4.872

7.  Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer.

Authors:  Ann H Partridge; Karen Sepucha; Anne O'Neill; Kathy D Miller; Christine Motley; Ramona F Swaby; Bryan P Schneider; Chau T Dang; Donald W Northfelt; George W Sledge
Journal:  JAMA Oncol       Date:  2015-06       Impact factor: 31.777

8.  Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.

Authors:  Shoshana M Rosenberg; Michaela S Tracy; Meghan E Meyer; Karen Sepucha; Shari Gelber; Judi Hirshfield-Bartek; Susan Troyan; Monica Morrow; Lidia Schapira; Steven E Come; Eric P Winer; Ann H Partridge
Journal:  Ann Intern Med       Date:  2013-09-17       Impact factor: 25.391

9.  Worry about cancer progression and low perceived social support: implications for quality of life among early-stage breast cancer patients.

Authors:  Erika A Waters; Ying Liu; Mario Schootman; Donna B Jeffe
Journal:  Ann Behav Med       Date:  2013-02

10.  N-Acetylglucosaminyltransferase III (GnT-III) but not N-Acetylgalactosaminyltransferase-6 and 8 are Differentially Expressed in Invasive and In Situ Ductal Carcinoma of the Breast.

Authors:  Antônio Felix da Silva Filho; Gabriela Souto Vieira-de-Mello; Petra Barros Dos Santos; Moacyr Jesus Barreto de Melo Rêgo; Alfredo Ribeiro-Silva; Eduardo Isidoro Carneiro Beltrão
Journal:  Pathol Oncol Res       Date:  2019-01-28       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.